Jenny Wegert

Mutations in the SIX1/2 Pathway and the DROSHA/DGCR8 miRNA Microprocessor Complex Underlie High-Risk Blastemal Type Wilms Tumors

Jenny Wegert, Naveed Ishaque, Romina Vardapour et al. · Cancer Cell · 2015 · 300 citations

Genetics, Molecular Genetics, Small Rna +7

Gain of 1q As a Prognostic Biomarker in Wilms Tumors (WTs) Treated With Preoperative Chemotherapy in the International Society of Paediatric Oncology (SIOP) WT 2001 Trial: A SIOP Renal Tumours Biology Consortium Study

Tasnim Chagtai, Christina Zill, Linda Dainese et al. · Journal of Clinical Oncology · 2016 · 130 citations · Full text

Recurrent intragenic rearrangements of EGFR and BRAF in soft tissue tumors of infants

Jenny Wegert, Christian Vokuhl, Grace Collord et al. · Nature Communications · 2018 · 104 citations · Full text

Urology, Developmental Biology, Braf Intragenic Rearrangements +11

Multiple mechanisms of MYCN dysregulation in Wilms tumour

Richard D. Williams, Tasnim Chagtai, Marisa Alcaide-German et al. · Oncotarget · 2015 · 101 citations · Full text

Subtype-Specific <i>FBXW7</i> Mutation and <i>MYCN</i> Copy Number Gain in Wilms' Tumor

Richard D. Williams, Reem Al‐Saadi, Tasnim Chagtai et al. · Clinical Cancer Research · 2010 · 81 citations · Full text